Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Clasificación en acciones #28752
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Precio por acción
$0.45018154
Capitalización bursátil
$24.81M
Cambio (1 día)
1.47%
Cambio (1 año)
-56.57%
País
JP
Comercio SymBio Pharmaceuticals Limited (4582)

Categoría

Ratio P/B de SymBio Pharmaceuticals Limited (4582)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de SymBio Pharmaceuticals Limited, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de SymBio Pharmaceuticals Limited desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras